Bone reconstruction requires the use of autografts from patients' iliac crest (IC); for large-volume defects bone void fillers and autologous mesenchymal stem cells (MSCs) are often added. The Reamer/Irrigator/Aspirator (RIA) device provides the means of harvesting large amounts of autograft and additionally yields a waste bag containing MSCs, which is currently discarded. The aim of this study was to enumerate and characterise native MSCs from RIA waste bag and compare them to 'gold-standard' donormatched MSCs from IC bone marrow (BM). IC-BM from age matched trauma patients was used as control.
Introduction
Current reconstruction of large bone defects involves the use of autografts from the iliac crest (IC) of the pelvis (Dimitriou et al., 2011) . Although such autografts possess the correct mechanical properties, osteogenic cells and osteoinductive growth factors (Giannoudis et al., 2007) , their volume is small and their harvesting remains invasive and often painful to the patient. When the defect volume exceeds that of the available IC autograft, a 'graft expander' material is commonly used, in the form of a natural or synthetic scaffold (Lichte et al., 2011) . The advent of a reaming-irrigator-aspirator (RIA) device has opened a new opportunity for harvesting large amounts of autograft (Cox et al., 2011; Masquelet et al., 2012) . To its advantage, RIA-harvested autograft bone has good handling properties and is amenable for use as a sole alternative to the IC graft or as a graft expander, in conjunction with autologous IC bone marrow (BM) aspirate Giannoudis et al., 2013) .
The RIA procedure for bone graft harvesting ( Fig. 1 ) involves the collection of the saline used for irrigation in a 'waste' bag, which is normally discarded. It contains small particulate material mechanically released from the bone, with the recent data showing that it also contains live osteoprogenitor cells including mesenchymal stem cells (MSCs) (Porter et al., 2009; Cox et al., 2011) . It has been suggested that in addition to harvesting the graft material, the waste bag could be also utilised as an additional source of MSCs; these cells could be used instead of the autologous IC BM for complex grafting (Porter et al., 2009; Cox et al., 2011) . Our previous study showed that the liquid phase of RIA waste bags contained on average 45,000 native MSCs, which is equivalent, in some cases, to a litre of undiluted BM aspirate (Cox et al., 2011; .
To prove the presence of MSCs in any material, including the RIA fluid, culture-expansion and in vitro differentiation assays are commonly used (Porter et al., 2009; Cox et al., 2011) . In other words, the presence of MSCs is inferred by analysing their progeny whereas their native characteristics remain unknown. We were the first group to use the CD271 + phenotype to characterise native MSCs in the IC BM (Jones et al., 2002; and in long bones (Cox et al., 2012) , later confirmed independently (Buhring et al., 2007; Kuci et al., 2011; Tormin et al., 2011; Maijenburg et al., 2012; Rasini et al., 2013 
Materials and Methods

Sample collection and preparation
Ethical approval was granted by the Leeds Teaching Hospital NHS Trust Ethics Committee. Seventeen patients were recruited for this study (8 female: 9 male, the median age 52, range 18-84). Patients selected were those undergoing surgical revision of a non-united long bone fracture (femur/tibia/radius), and requiring RIA-reaming of the femur to obtain bone graft material. This was carried out on the contralateral side for previous femoral fractures or the ipsilateral side for previous tibial or radial fractures, by experienced orthopaedic surgeons as previously described (Cox et al., 2011) . The contents of the RIA waste bag were filtered through a sterile 70 µm sieve (Endecotts, London, UK) to remove solid fatty/bony fragments, which were discarded and the fluid saved for further processing as described below. Concomitantly, donor-matched IC BM was collected via an 11G introduction needle into heparin coated syringes ( Fig. 1 ) and immediately transferred to EDTA-containing tubes for further processing. The median volumes (range) for RIA fluid and IC BM aspirates were 700 mL (450-2000 mL) and 18 mL (15-22 mL), respectively. The volume of the RIA fluid was determined by the surgeon and related to the procedure and minimal amount of graft needed, rather than the dimensions of the bone being reamed. In addition to the donor-matched IC BM, further control IC BM aspirates from patients undergoing surgery following trauma, and not for treating an atrophic nonunion, were obtained from seven individuals (range 25-60 years, median 36 years).
MSC enumeration using colony-forming unitfibroblast (CFU-F) assay and flow cytometry for the CD271 + cell population Triplicate CFU-F assays were performed using 100 μL sample directly plated into Nonhaematopoietic (NH) medium (Miltenyi Biotec, Bisley, UK) in 100 mm dishes (Corning, NY, USA) as previously described . For flow cytometry validation, the RIA fluid was centrifuged to minimise the volume, before isolating mononuclear cells (MNCs) using a Lymphoprep ® density gradient (Axis-Shield, Dundee, UK); CD271 + cells were subsequently enumerated as described previously (Cox et al., 2012) .
MSC sorting based on the CD271
+ phenotype The MNCs from the RIA fluid and control IC BM aspirates were isolated using Lymphoprep and CD271
+ cells were first pre-enriched with Anti-Fibroblast Microbeads (Miltenyi), as described previously Jones et al., 2010) . The MSC population: CD45 -/ low CD271 + , together with the control haematopoietic lineage cell (HLC) population; CD45 + CD271 -, was purified by cell sorting, using CD45-FITC (Dako, Stockport, UK), CD271-PE (BD Biosciences, Oxford, UK) and 7-AAD (Sigma, Gillingham, UK), the latter used to eliminate dead/dying cells, on a MoFlo cell sorter (Dako, Ely, UK), directly into lysis buffer (Norgen Biotek, Thorold, Canada).
Quantitative real-time PCR (qPCR)
RNA (n = 12) was isolated from cell lysates using the Norgen Biotek RNA/DNA/protein kit (Geneflow, Lichfield, UK). cDNA was reverse transcribed using High Capacity cDNA reverse transcription kit for use on a Custom Taqman Array (format 48) (both Life Technologies, Paisley, UK). Based on the manufacturer's recommendation, 200 ng cDNA was used per sample where possible, alternatively all available cDNA was used. Low concentrations could result in some missing data, but this was rarely the case. Analysis was carried out using the 2 -ΔCt method normalising to the reference gene HPRT. Genes included those previously found to be specific for CD271 + IC-BM MSCs (examples: BMP2, SPP1, BGLAP, FABP4, SOX9, WIF1 and FRZB) as well as new molecules, chosen to be associated with the hypoxia pathway (HIF1A, HIF1AN, VHL, ARNT, EGLN1) and MSC angiogenic support (VEGFA, VEGFB, VEGFC, PGF) . Taqman assays for all 48 transcripts studied are shown in Tables 1 and 2 . n = 12 donors, BD = below detection, LD = low detection (n ≤ 2).
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Extended phenotypic analysis of the RIA fluid by 6-colour flow cytometry Following density gradient separation using Lymphoprep, cryogenically stored MNCs (n = 3 donors, age range 28-55) were thawed and re-suspended at 1 x 10 7 cells/mL FACS buffer (phosphate-buffered saline, PBS/0.5 % bovine serum albumin, BSA). Combinations of the following antibodies were used according to manufacturers' recommendations and incubated for 20 min: CD19-PE, CD33-FITC, CD34-PcCy5.5P, CD45-PECy7, CD61-FITC, CD73-PE (all BD Biosciences), CD31-FITC, CD90-PE, CD105-PE (all Serotec, Oxford, UK) and CD271-APC (Miltenyi). Isotype controls were from BD Biosciences. CD73, CD90 and CD105 were used as additional MSC markers (Buhring et al., 2007; Jones et al., 2006) , whereas CD19, CD33, CD61 and CD31 were used to identify other cell lineages (B-, myeloid-, megakaryocytic and endothelial cells, respectively). The cells were washed and re-suspended in FACS buffer containing 100 ng/mL DAPI (Sigma-Aldrich, Poole, UK) before analysing on an LSRII flow cytometer. DAPI-positive dead/dying cells were excluded before gating of the CD271 + cells and HLCs for the assessment of marker expression on these cell populations.
Statistical analysis
Matched statistical analysis was carried out using the Wilcoxon Signed Ranks test for paired IC BM and RIA fluid samples. Multiple grouped analysis was performed using the Kruskal-Wallis test with Bonferroni-Dunn correction. All comparative statistics and graphs were produced using Graphpad (La Jolla, CA, USA) Prism 5; where data is shown as box-whisker plots, each box represents upper to lower quartile, with the line representing the median; whiskers represent maximum and minimum values. A single dot represents one value.
Correlations were determined using Spearman's rho and normality testing (Kolmogerov-Smirnov test) of sample information (i.e., volumes and CFU-F counts) were performed using IBM SPSS Statistics 19; only sample volumes were found to be normally distributed.
Results
MSC yield of RIA fluid compared to IC aspirate
We initially endeavoured to validate our previous calculations of the high yield of MSCs in the RIA waste (Hernigou et al., 2005) . In every patient, CFU-F numbers in RIA waste bags exceeds the minimum value.
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bag, compared to IC BM aspirate, using a larger and different cohort of patients (14 versus previous 6 (Cox et al., 2011) ). The frequency of MSCs, measured as CFU-F per mL was similar in the two sources (p = 0.660, Fig. 2 a,b). We were mindful that patients suffering from nonunion could be characterised by a reduced IC BM MSC frequency (Seebach et al., 2007) . However, when the CFU-F assay for MSC enumeration was performed using IC BM aspirate from control trauma patients and compared to an age-matched subgroup of IC BM from the non-union cohort, no significant differences were found (485 versus 700 CFU-F/mL, n = 7 and 8 patients, respectively Fig. 2c ).
Given that the volume of the RIA fluid (including saline used for irrigation) was 39-fold larger than IC BM aspirate, the total CFU-F yield in the RIA fluid was 59-fold higher (p = 0.0001). For every donor tested, the total number of RIA-CFU-Fs was greater (Fig. 2d) than the minimum therapeutic MSC dose required for non-union fracture repair according to Hernigou (Hernigou et al., 2005) . Based on the median number of CFU-F/mL in IC BM aspirate (328/mL from the whole non-union group), + cells from donor-matched IC BM aspirate were used as controls (Fig.  3 a,b) . In our previous studies, we used the CD45 + CD271 -cell population (haematopoietic lineage cells, HLCs) as non-MSC 'negative' controls Cox et al., 2012) , the same strategy was used in the present study (Fig. 3a, left panels) .
As seen on Fig. 3b , CD271 + cells derived from both IC BM aspirate and RIA fluid were positive for classical MSC markers CD73 and CD90 (Dominici et al., 2006; VeyratMasson et al., 2007) . The expression of CD105, another well-known MSC marker (Barry et al., 1999; Pittenger et al., 1999) was slightly lower compared to CD73 and CD90, as described previously (Martinez et al., 2007; Cox et al., 2012) , but remained highly specific for CD271 + cells. Consistent with their non-haematopoietic nature, CD271 + cells from both sources did not express markers for haematopoietic progenitors (CD34), megakaryocytes/ platelets (CD61), B-cells (CD19), endothelial cells (CD31) and myeloid cells (CD33). Representative histograms are shown on Fig. 3b , bottom panels. Following culture expansion, trilineage differentiation was performed on MSCs from this source in Cox et al. (Cox et al., 2011) .
IC BM-and RIA fluid-derived CD271 + cells were next sorted for gene expression analysis. The purity of the sorted fractions was validated by qPCR for NGFR, the gene encoding the CD271 protein (Fig. 3a , right panels). For both IC-and RIA fluid-derived samples, the expression of NGFR in CD271 + cells was over 300-fold higher compared to the corresponding HLCs (367-and 386-fold, respectively), confirming their purity.
The gene expression analysis revealed that genes typically associated with MSC lineage potentiality: FABP4 (fat-lineage specific transcript) and SPP1 (osteopontin, bone-lineage specific transcript) were preferentially expressed in RIA-CD271
+ cells compared to RIA-HLCs; a pattern similar to IC BM CD271 + cells and HLCs (Fig.  3c) .
Together, these results revealed that RIA-CD271 + cells had phenotypic and molecular characteristics consistent with MSCs. This was further confirmed by a significant correlation (rho = 0.538, p = 0.047) observed between total CFU-F and the number of CD271 + cells sorted from the RIA fluid.
Molecular comparison between iliac crest and RIA fluid: bone-and Wnt pathway-related molecules
The Wnt pathway plays a key role in bone development and differentiation of MSCs towards bone, cartilage and fat lineages (Etheridge et al., 2004; Takada et al., 2009) . In our previous study we demonstrated extensive Wnt pathwaysignalling activity in CD271 + MSCs from IC BM aspirate . Amongst the seven detectable canonical Wnt pathway transcripts chosen for this study, six transcripts (two surface receptors and four regulatory molecules) were highly specific for CD271 + MSCs (Fig.  4a) ; amongst those only LRP5 expression was reduced in the RIA-CD271
+ group compared to donor-matched IC-CD271 + (Fig. 4a, Table 1 ). Interestingly and in agreement with our previous study , Wnt pathway regulators, particularly FRZB, displayed the highest specificity for CD271 + MSCs (Fig. 4a) suggesting that these molecules can potentially serve as novel markers of MSCs in cell tracking studies using animal models (Kurth et al., 2011) .
We were aware that patients suffering non-union could be characterised by reduced expression of bone-related molecules (Seebach et al., 2007) . We therefore compared the expression of such molecules in IC and RIA CD271 + MSCs from a subgroup of the non-union patients to the CD271 + MSCs of age-matched control trauma patients (Fig. 4b) . A multiple comparison test (Kruskal-Wallace, with multiple group correction) revealed no significant differences in the expression of BMP2, COL1A2, OMD (osteomodulin) and TNFRSF11B (osteoprotegrin) in the three groups studied. The only exception was the trend for a lower expression of SPARC (osteonectin) in RIA-MSCs from non-union patients compared to trauma IC controls, which reached statistical significance for RIA CD271 + MSCs (Fig. 4b) .
Altogether, these data confirmed our previous findings pertaining to highly-specific Wnt signalling activity in CD271 + MSCs and extended these observations to MSCs resident in long bones (those harvested in RIA bags). Secondly, we showed that the expression of bone-related molecules in RIA CD271 + MSCs was similar to donormatched IC BM CD271 + MSCs. Finally, together with our numerical data on the abundance of MSCs in RIA waste bags (Fig. 3c) , the above gene transcript data indicated that patients suffering non-union had a broadly similar bone transcript expression profile (IC-and RIA-derived MSCs), to that of a control group of trauma patients.
Molecular comparison between iliac crest and RIA fluid: molecules related to local MSC topography
Despite their intra-osseous origin, topographical differences in MSCs recovered from different types of bones do exist (Akintoye et al., 2006) . More recently, MSCs have been topographically linked to both pericytes (Caplan, 2008; Crisan et al., 2008; Meirelles et al., 2008; Caplan SM Churchman et al. Molecular profile of MSCs and Correa, 2011) and bone-lining cells (Tormin et al., 2011; Rasini et al., 2013) . In agreement with the 'MSC as a pericyte' theory (Caplan, 2008; Caplan and Correa, 2011) , pericyte-specific PDGFRA, ANGPT1 and MCAM were expressed in both IC BM and RIA CD271 + MSCs (Fig. 5a ). MCAM expression was however significantly reduced in RIA CD271
+ MSCs (~15-fold, Table 1 ). Interestingly, we observed a trend for the reduced MCAM expression in relation to the volume of the RIA fluid harvested (rho = 0.55, not significant).
We additionally tested the expression of angiogenesisand hypoxia-related molecules, based on a hypothesis that long bone MSCs could have originated from a lower oxygen environment compared to IC BM MSCs. Amongst 13 angiogenesis-and hypoxia-related molecules (HIF1A, HIF1AN, ARNT (HIF1β), EGLN1, ANGPT1, ANGPTL4, PGF, VEGFA, VEGFB, VEGFC, FLT1 (VEGFR1) , KDR (VEGFR2) and VHL, five were down-regulated in RIA-CD271 + MSCs (Fig. 5b , Table 1 ). These molecules included two HIF pathway regulators EGLN and HIF1AN and two target genes PGF and VEGFC (Fig. 5b) . Two other target genes however, VEGFA and VEGFB, displayed no downregulation in RIA-CD271 + MSCs (Table 2) suggesting that the observed down-regulation in RIA CD271
+ MSCs was unlikely to be vital.
Molecules with very low levels of expression
Of the gene transcripts tested in the 48-gene array, Wnt ligand WNT2, BMP7 and the myogenic transcription factor MYOD1 were detected in two or fewer samples for all fractions and the late chondrogenic marker aggrecan (ACAN) was undetected in all samples ( Table 2 ). The lack of transcript expression for this mature chondrogenesisrelated protein in native CD271 + MSCs is consistent with our previous study and indicates the absence of active chondrogenesis in both cancellous and cortical bone. Lower levels of endogenous BMP7 expression, as opposed to BMP2, are additionally noteworthy given the widespread use of both agents in the treatment of fractures and their differential expression during fracture repair (Bishop and Einhorn, 2007; Yu et al., 2010 , Kloen et al., 2012 .
Altogether, the transcript expression data showed that 34/45 (75.6 %) tested molecules were similar in their expression between IC and RIA CD271 + MSCs, which support the use of RIA waste bags, instead of IC BM aspirate concentrate (Kasten et al., 2008) , as a source of MSCs in complex bone grafting procedures.
Discussion
Earlier findings pertaining to RIA-harvested MSCs have relied on MSC culture-expansion and testing of their tripotentiality in vitro (Porter et al., 2009; Cox et al., 2011) . This study, for the first time, explored the molecular signature of highly-pure MSCs immediately following their extraction, which represents the MSC's native state in vivo and is unaffected by any culture manipulations, which usually lead to transcript down-regulation Qian et al., 2012) . Common molecular signatures of IC and RIA MSCs suggest that RIA waste bags may be a viable alternative to IC BM aspirate in complex bone grafting procedures.
Initially, we tested the practicality of this approach in terms of actual numbers of MSCs harvested. In full agreement with our previous study (Cox et al., 2011) , the calculated quantity of MSCs obtained by the average reaming of a single long bone (femur) was found to be equivalent to 958 mL of IC aspirate; notably, such a large volume aspiration would be neither ethical nor practical due to a gradual dilution of marrow with blood . Such a significant number of MSCs obtained from a single donation suggests that RIA waste bags could represent a unique resource of MSCs not only for autologous, but also for allogeneic applications. To explore this possibility and to address potential concerns pertaining to the 'inferiority' of MSCs from patients suffering nonunion, we additionally investigated donor-matched IC BM MSCs and MSCs from a control cohort of trauma patients and no major differences in the MSC numbers or their bone-related gene expression was found. Overall, the 'quality' of RIA MSCs was similar to IC MSCs (75.6 % similarity based on our gene panel); this confirms the possibility of developing new technologies and devices for the concentration and purification of RIA MSCs to be used as therapy (Porter et al., 2009) . Parallel removal of immune cells and selection of immuno-privileged MSCs (Tyndall et al., 2007) could permit their allogeneic transplantation; a proof-of-principle animal study would be required to demonstrate this point.
From a basic science point of view, we observed that transcripts from the Wnt and hypoxia signalling pathways, known to regulate bone formation and angiogenesis (Etheridge et al., 2004) , were overall similar between IC and RIA MSCs suggesting that the steady-state MSC activity in both locations (IC and long bone) was comparable. Gene expression profiles of CD271 + cells from both locations were consistent with native MSCs (MendezFerrer et al., 2010; Tormin et al., 2011; Qian et al., 2012) and only subtle differences in expression of the selected genes were found. As shown recently, the expression of Wnt pathway transcripts in particular is considerably down-regulated or even lost during standard culture expansion Qian et al., 2012) ; this highlights the importance of purifying and analysing native MSC populations, and not cultured MSCs, when comparisons of 'MSC fingerprints' in different tissues are sought.
When BM is removed from human long bones manually (by scooping), it contains only 2-to 5-fold more MSCs, compared to IC BM (Cox et al., 2012) . This suggests that significantly greater numbers of MSCs recovered by reaming were most likely derived from the endosteum, which is disrupted by reaming but left intact during manual collection. This notion is supported by a recent demonstration that bone-lining cells are positive for CD271 but largely negative for CD146 (Tormin et al., 2011; Rasini et al., 2013) . This study, in which significantly lower levels of MCAM/CD146 were found in RIA-CD271
+ MSCs compared to those of the IC, supports the idea that at least some of RIA-harvested MSCs have originated from the SM Churchman et al.
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inner bone surface and cortex (Tormin et al., 2011) . This is further supported by an observed reduction in MCAM/ CD146 expression with the increased volume of RIA fluid harvested, the latter being primarily related to the depth of cortex reamed, and by the reduction in the expression of several hypoxia pathway-related transcripts as cortex is known to be more hypoxic. This study is limited by the use of IC BM samples from trauma patients, not healthy volunteers, as controls; this was limited by ethical considerations. Additionally, we cannot exclude the possibility that the observed differential expression for some molecules between IC and RIA MSCs was a result of the more invasive harvesting process; however, this is rather unlikely as the same significant decreases were not observed in the control HLCs. The use of purified MSCs and negative control HLCs from the same patient was a major advantage of this study. In a recent molecular study of bony chips obtained by RIA (Sagi et al., 2012) , whole tissues extracted from IC and long bones were used. The interpretation of gene expression data was therefore limited by the heterogeneous nature of tissues studied making conclusions relating to MSCs less robust (Sagi et al., 2012) .
In summary, this study has identified a normally discarded RIA by-product that can provide an abundant, non-inferior, alternative source of native MSCs compared to IC. Such is the wealth of these cells that they may not only become an osteogenic source for future 'singlesurgery' autologous use, but also -with further studymay present a reservoir of cells for allogeneic bone repair applications. The present findings therefore bode well for the in vivo testing of bone-forming capability of MSCs concentrated from RIA waste bags in animal models. 
